Stroke is a leading cause of long-term disability in adults. Although many individuals regain independent walking ability following stroke, nearly 50% experience persistent gait impairments characterized by asymmetrical walking patterns, slower walking speed, impaired balance, and increased fall risk. These persistent mobility limitations highlight the continued need for innovative rehabilitation strategies that improve gait function during stroke recovery. Split-belt treadmill walking (SBTW), in which each leg walks at a different belt speed, has demonstrated potential to improve step length symmetry in individuals with chronic stroke. However, the effects of SBTW during the subacute stage of stroke recovery, within the first 9 months post-stroke when neuroplasticity may be heightened, remain largely unknown. In addition, previous SBTW studies have not integrated active physiotherapist-led gait retraining into the intervention, despite physiotherapist-led gait rehabilitation representing standard clinical care following stroke. The purpose of this randomized controlled trial is to compare physiotherapist-led gait retraining using a traditional treadmill training protocol to physiotherapist-led gait retraining integrated with a split-belt treadmill training protocol during the first 9 months post-stroke. The study aims to examine the effectiveness of the use of split-belt treadmill training to augment physiotherapist-led gait retraining to improve between-leg gait symmetry and overground walking speed.

Inclusion Criteria:

• unilateral stroke resulting in hemiparesis
• less than 9 months post-stroke
• ability to walk ten metres with or without walking aids
• ability to stand without support for five minutes
• English speaking

Exclusion Criteria:

• medically unfit to participate e.g. cardiac or respiratory disease limiting ability to perform walking tasks
• neuromuscular impairment, other than stroke, limiting mobility, e.g. ankle sprain, joint disease such as severe arthritis
• cognitive/communication impairment impacting ability to follow instructions
• diagnosis of clinical depression or anxiety disorders requiring medication

IPD that underlie results in a publication will be shared.

Beginning 3 months and ending 3 years after the publication of results

The PI will accept a proposal that describes planned analyses and assess the need for a data sharing agreement.